Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-1 infection.
Churchill
D R
DR
Pym
A S
AS
Babiker
A G
AG
Back
D J
DJ
Weber
J N
JN
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000150:complications; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects; D019258:Saquinavir / Q000009:adverse effects; D014280:Triglycerides / Q000378:metabolism
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D014280:Triglycerides; D019258:Saquinavir; D019438:Ritonavir